(E) Johnson & Johnson has just announced, that in partnership with the US federal government, it will invest more than $1 billion in a potential vaccine, developed at the Beth Israel Deaconess Medical Center led by Professor Dan Barouch, against the SARS-CoV-2.
The clinical trials, for that vaccine, are planned to start by September, and if there are successful, the vaccine could be ready for emergency use early next year.
A video from NBC Boston on Professor Barouch’s research:
Johnson & Johnson’s press release:
- Johnson & Johnson Announces a Lead Vaccine Candidate for COVID-19; Landmark New Partnership with U.S. Department of Health & Human Services; and Commitment to Supply One Billion Vaccines Worldwide for Emergency Pandemic Use
An article on the Johnson & Johnson’s announcement from the Boston Globe:
Note: The picture above is a view of Boston downtown.
Copyright © 2005-2020 by Serge-Paul Carrasco. All rights reserved.
Contact Us: asvinsider at gmail dot com